Updated:
Formal status
Do we sell here?
Not at the moment.
Outlook
Timeline
August 2019
Joint operation by Politie Westkust, FOD Volksgezondheid, the FAVV and Customs at a CBD shop in Oostduinkerke, with a simultaneous action at a comparable shop in Antwerp. The entire stock of CBD oil bottles and the full quantity of tea were seized on the ground that the goods "bevatten meer verdovende middelen dan wettelijk toegestaan". Both targets were Belgian-established physical shops.
Politie WestkustAugust 2021
Royal Decree of 31 August 2021 on foodstuffs containing plants places Cannabis sativa L. on List 1 of "dangerous plants", so foodstuffs and food supplements containing it may not be marketed in Belgium. The FPS Health FAQ states that e-commerce is caught as well: CBD oil "ne peut donc pas être commercialisée au sein de l'Union européenne (e-commerce interdit également)".
SPF Santé publique — FAQ Cannabis (February 2025 version)April 2024
Royal Decree of 24 April 2024 (Moniteur belge 22 May 2024, in force 1 June 2024) raises the scheduling threshold in Annexes IA and IVB of the Royal Decree of 6 September 2017 from 0.2% to 0.3%. Cannabis resin, extracts and tinctures are scheduled narcotics only where the sum of Δ9-THC and THCA concentrations exceeds that figure; below it they are not scheduled at all.
Arrêté royal du 6 septembre 2017 — consolidated text (JUSTEL)January 2026
AFMPS states that foodstuffs and food supplements containing parts of the cannabis plant "qui prétendent soulager la douleur ou les problèmes de sommeil" fall under medical cannabis, are not authorised as medicines in Belgium, and are therefore "vendus illégalement". The position turns on the combination of a cannabis-plant ingredient and a therapeutic claim, moving such products into AFMPS competence rather than that of FPS Health.
AFMPS — Médicaments et autres produits à base de cannabis ou cannabidiol